JPRN-UMIN000019843已完成3 期
Carboplatin plus nab-Paclitaxel versus docetaxel for elderly squamous non-small cell lung cancer (CAPITAL study) - CBDCA+nab-PTX vs DOC for eldery Sq NSCLC Phase III study
ational Hospital Organization Nagoya Medical Center0 个研究点目标入组 250 人开始时间: 2015年11月20日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 70years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) symptomatic central nervous system metastases 2) A past hypersensitive for polysorbate or albmin 3) peripheral neuropathy CTCAE Grade 2 or more 4) uncontrolled pericardial or pleural effusion or ascites 5) prior palliative radiotherapy for metastatic lesion within 14 days before registration 6) Synchronous or metachronous active double malignancies 7) Infectious disease requiring systemic treatment or severe complications 8) do not consent to contraception 9) Positive for HBs antigen 10) positive for HBs antibody or HBc antibody, and positive for HBV-DNA 11) patients who have been judged by the invedtigator to be inappropriate in this clinical trial for other reasons
研究者
相似试验
进行中（未招募）
不适用
Carboplatin + paclitaxel vs carboplatin + stealth liposomal doxorubicin. A randomised multicentre trial.EUCTR2004-002399-40-DKRigshospitalet530
已完成
2 期
Phase 2 study of Carboplatin plus nab-Paclitaxel for patients with PS 2 advanced NSCLC(TORG1426)on small cell lung cancerJPRN-UMIN000019458PO Thoracic Oncology Research Group42
已完成
2 期
Phase II study of Carboplatin plus nab-Paclitaxel for advanced non-small cell lung cancer patients with interstitial lung diseaseAdvanced non-small cell lung cancer with interstitial lung diseaseJPRN-UMIN000012989Kanagawa Cardiovascular and Respiratory Center90
已完成
2 期
Phase II study of Carboplatin + nab-Paclitaxel followed by nab-Paclitaxel with chemotherapy naive advanced Non- Small Cell Lung CancerChemotherapy naive non-small cell lung cancerJPRN-UMIN000015144Fukuoka University School of Medicine40
招募中
3 期
Chemoradiation for advanced unresectable esophageal and gastroesophageal junction cancerCTRI/2018/08/015564TATA MEMORIAL HOSPITA